DiscoverGet It Done: Stories Around Manufacturing SuccessGet It Done Episode 6: The Future of CBD - Regulation, Start-ups, and Cost Insights with Gary Purk
Get It Done Episode 6: The Future of CBD -  Regulation, Start-ups, and Cost Insights with Gary Purk

Get It Done Episode 6: The Future of CBD - Regulation, Start-ups, and Cost Insights with Gary Purk

Update: 2024-02-23
Share

Description

Gary Purk is the CEO of ChyloCure, a startup specialising in a unique magnesium-infused CBDa compound – a next-generation CBD product which is superior to CBD. He joins the show to talk about the economics of direct-to-consumer models versus traditional distribution channels, focusing particularly on the hurdles of maintaining low customer acquisition costs. 

Gary unpacks the product's health benefits, the substantial cost analysis beyond the production line, and the impact of imminent industry regulation changes. He also reflects on the risks and rewards associated with managing inventory, compliance costs, and marketing in an industry filled with both potential and pitfalls.


Website: https://chylocure.com/ 
Twitter: https://twitter.com/purkgary 
LinkedIn: https://www.linkedin.com/in/garypurk/ 


Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Get It Done Episode 6: The Future of CBD -  Regulation, Start-ups, and Cost Insights with Gary Purk

Get It Done Episode 6: The Future of CBD - Regulation, Start-ups, and Cost Insights with Gary Purk

Ivan Jenkins